Back

Efficacy of plaque debulking for bifurcated or ostial lesion by directional coronary atherectomy before 2nd generation drug eluting stent (PERFECT2)

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - High risk percutaneous coronary intervention: STEMI, CTO, atherectomy bifurcations shock Devices ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Maoto Habara

Toyohashi Heart Center, Toyohashi (Japan)

26 More presentations in this session

Presentation thumbnail
Doctor D. Topal (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Doctor A. Pavlovic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Doctor C. O'connor (Limerick, IE)
Abstract Slides
Presentation thumbnail
Associate Professor D. Maximkin (Moscow, RU)
Abstract
Presentation thumbnail
Doctor D. Milasinovic (Belgrade, RS)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - High risk percutaneous coronary intervention: STEMI, CTO, atherectomy bifurcations shock

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Which is the best stenting technique for coronary bifurcation lesions? Evidence from a network meta-analysis of randomized clinical trials
3 September 2019
thumbnail
Congress Presentation
Serial OCT assessment after directional coronary atherectomy followed by drug-coated balloon: 3 months, 7 months, and 1.5 years
1 September 2025
thumbnail
Congress Presentation
A novel cardiac computed tomography-based calcium scoring system for predicting the use of debulking devices in severely calcified coronary lesions: CT-CALC score
29 August 2025
thumbnail
Congress Presentation
Second-generation drug-eluting stents versus coronary artery bypass surgery in patients with stable angina and an isolated lesion in the proximal left anterior descending artery
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources